7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Apexigen, Inc.
(NASDAQ:APGN) 

APGN stock logo

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as mela...

Founded: 2010
IPO Price: $10 (Jul 29, 2022)
Full Time Employees: 22
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Apexigen . Op Cashflow Per Share ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,551.15-1,327.39-1,103.63-879.87-656.11-432.35-208.5915.17
Apexigen . Free Cashflow Per Share ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,554.03-1,329.86-1,105.69-881.52-657.35-433.18-209.0115.17
Apexigen . Cash Per Share ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0121.28242.57363.85485.13606.42727.7848.98
Apexigen . (GAAP) P/E ratio ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.36-0.31-0.26-0.2-0.15-0.1-0.050
Apexigen . P/B ratio ttm
202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -4.1-2.89-1.69-0.480.731.933.144.35
No extra charts and metrics for this ticker.